Adherence Measures for Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate plus Prednisone: Results of a Prospective, Cluster-Randomized Trial

SIMPLE SUMMARY: We report the final results of a multicenter, prospective, 2-arm trial in a real world setting for patients with metastatic castration resistant prostate cancer. A number of 675 patients were allocated by center-based cluster-randomization to arm A with adherence enhancing measures o...

Descripción completa

Detalles Bibliográficos
Autores principales: Suttmann, Henrik, Gleissner, Jochen, Huebner, Andreas, Mathes, Tim, Baurecht, Werner, Krützfeldt, Katrin, Sweiti, Hussein, Feyerabend, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564106/
https://www.ncbi.nlm.nih.gov/pubmed/32911627
http://dx.doi.org/10.3390/cancers12092550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564106/
https://www.ncbi.nlm.nih.gov/pubmed/32911627
http://dx.doi.org/10.3390/cancers12092550

Ejemplares similares